enGene Holdings Inc.
ENGN
$8.65
-$0.17-1.87%
NASDAQ
07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 20.10% | 26.58% | 85.02% | 149.76% | 258.78% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 82.94% | 96.44% | 142.66% | 139.05% | 149.51% |
Operating Income | -82.94% | -96.44% | -142.66% | -139.05% | -149.51% |
Income Before Tax | 23.01% | 29.47% | 33.14% | 44.78% | -374.93% |
Income Tax Expenses | 2,557.14% | 3,000.00% | 323.08% | -211.76% | -195.45% |
Earnings from Continuing Operations | 22.58% | 29.26% | 33.10% | 44.81% | -374.44% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 22.58% | 29.26% | 33.10% | 44.81% | -374.44% |
EBIT | -82.94% | -96.44% | -142.66% | -139.05% | -149.51% |
EBITDA | -83.25% | -96.84% | -143.36% | -139.65% | -150.22% |
EPS Basic | 98.40% | 98.70% | 98.88% | 98.99% | -253.70% |
Normalized Basic EPS | 95.02% | 95.90% | 96.78% | 97.45% | -59.65% |
EPS Diluted | 98.40% | 98.70% | 98.88% | 98.99% | -253.70% |
Normalized Diluted EPS | 95.02% | 95.90% | 96.78% | 97.45% | -59.65% |
Average Basic Shares Outstanding | 83.71% | 197.57% | 607.53% | 5,388.28% | 1,774.54% |
Average Diluted Shares Outstanding | 83.71% | 197.57% | 607.53% | 5,388.28% | 1,774.54% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |